SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 107.17 |
| Enterprise Value ($M) | 71.12 |
| Book Value ($M) | 318.73 |
| Book Value / Share | 2.78 |
| Price / Book | 0.34 |
| NCAV ($M) | 169.94 |
| NCAV / Share | 1.48 |
| Price / NCAV | 0.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.46 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.58 |
| Current Ratio | 7.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 291.91 |
| Assets | 440.69 |
| Liabilities | 121.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 13.63 |
| Operating Income | -195.54 |
| Net Income | -186.26 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -122.87 |
| Cash from Investing | 12.22 |
| Cash from Financing | 99.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Redmile Group, LLC | 14.90 | 1.12 | |
| 13G/A | Point72 Asset Management, L.P. | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 9.20 | 0.00 | |
| 13G/A | Boxer Capital Management, LLC | 4.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 290,493 | 1,295,417 | 22.42 | |
| 187,764 | 833,064 | 22.54 | |
| 382,550 | 1,825,955 | 20.95 | |
| 641,138 | 2,165,381 | 29.61 | |
| 1,434,146 | 4,348,139 | 32.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ESPR – Esperion Therapeutics, Inc. | ETNB – 89bio, Inc. |
| ETON – Eton Pharmaceuticals, Inc. | FHTX – Foghorn Therapeutics Inc. |
| FOLD – Amicus Therapeutics, Inc. |